SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to a reported surge in revenue and a small float, sparking excitement about a potential massive run. The community is focused on the stock's low float and are watching for news catalysts, drawing comparisons to other stocks with similar setups. Some traders are also pointing to the stock's chart patterns as a reason for optimism.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to discussions surrounding Amazon's competitive moves in the DSP space, sparking debates about market share and potential impacts. The community is analyzing Amazon's recent offer of head-to-head testing and ADWEEK's reporting of it. Investors are closely watching Trade Desk's response and its long-term strategies in a competitive landscape.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community actively discussing the potential market impact and likelihood of approval. While some express concerns about potential side effects and a history of sell-offs post-approval, others point to the drug's efficacy and the company's strong financial position, anticipating a significant upside if approved. Community members are closely monitoring discussions around analyst price targets, short interest, and potential buyout scenarios.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as retail traders discuss a potential short squeeze, with community members pointing to high borrowing costs for short sellers and a limited float. Talk centers around a large buy order that could trigger significant upward movement. Some traders are comfortable holding shares while others are looking for an entry point or taking profits.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending due to after-hours price action and community speculation about a potential short squeeze or upcoming news, despite the company stating they are unaware of any material changes. Traders are actively discussing potential price movements and the possibility of dilution, creating volatility. The stock's movement is also attracting attention as a potential play in the medical sector.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

GNTA is experiencing significant volatility, with community members actively discussing a large pre-market surge following news of a strategic partnership. The conversation includes speculation about a short squeeze, potential for further gains, and caution due to the stock's history of volatile price action and possible pump and dump schemes. Some traders are taking profits while others are holding in anticipation of after-hours movement.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is trending as the community emphasizes its potential for profit, particularly its availability on Phantom Wallet. The conversation highlights a blend of 'ancient' and 'modern' gains, with users frequently mentioning fire and wisdom as key themes. The coin's association with other Solana tokens is also part of the discussion.

U.S. Gold Corp. engages in the exploration of gold properties. It has properties in CK Gold Project, Wyoming, Challis Gold Project, Idaho, and Keystone, Nevada. The company was founded in 1967 and is headquartered in Elko, NV.

U.S. Gold Corp

U.S. Gold Corp ($USAU) is trending as investors discuss its potential spin-off of the Keystone project and debt financing options expected by year-end. Bullish sentiment is fueled by rising gold prices and upcoming Russell index inclusion, while some community members express concerns about management experience and potential dilution. Discussions also involve price targets and speculation about institutional accumulation.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva is trending as community members discuss its potential and setbacks, with some pointing to a recent FDA approval for Uzedy as a positive catalyst. Despite some positive news, negative sentiment persists regarding the stock's performance and leadership. Analysts are weighing in, with price target adjustments and discussions around the company's "Pivot to Growth" strategy.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid community discussion around a recent FDA investigation into allergic reactions linked to specific lots of intravenous immune globulin (IVIG) drugs, including two ADMA products; although these reactions are acknowledged as rare, the news has sparked concerns and trading volatility. Some investors view the dip as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run, while others express frustration with the stock's recent performance and management's silence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HYZON ANNOUNCES DELISTING FROM NASDAQ AND EXPECTED SEC DEREGISTRATION

HYZON ANNOUNCES DELISTING FROM NASDAQ AND EXPECTED SEC DEREGISTRATION HYZON ANNOUNCES DELISTING FROM NASDAQ AND EXPECTED SEC DEREGISTRATION PR Newswire BOLINGBROOK, Ill., Feb. 20, 2025 BOLINGBROOK...

HYZON RECEIVES ORDER FOR REFUSE COLLECTION AND CLASS 8 200KW FUEL CELL ELECTRIC TRUCKS FROM SOUTH SAN FRANCISCO SCAVENGER COMPANY

HYZON RECEIVES ORDER FOR REFUSE COLLECTION AND CLASS 8 200KW FUEL CELL ELECTRIC TRUCKS FROM SOUTH SAN FRANCISCO SCAVENGER COMPANY HYZON RECEIVES ORDER FOR REFUSE COLLECTION AND CLASS 8 200KW FUEL...

HYZON ANNOUNCES SUCCESSFUL TRIAL COMPLETION OF NORTH AMERICA'S FIRST FUEL CELL POWERED REFUSE TRUCK WITH MT. DIABLO RESOURCE RECOVERY

HYZON ANNOUNCES SUCCESSFUL TRIAL COMPLETION OF NORTH AMERICA'S FIRST FUEL CELL POWERED REFUSE TRUCK WITH MT. DIABLO RESOURCE RECOVERY HYZON ANNOUNCES SUCCESSFUL TRIAL COMPLETION OF NORTH AMERICA'S...

HYZON ANNOUNCES THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

HYZON ANNOUNCES THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS HYZON ANNOUNCES THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS PR Newswire BOLINGBROOK, Ill., Nov. 13, 2024 Secured first...

A Look Ahead: Hyzon Motors's Earnings Forecast

HYZON ANNOUNCES COMPLETION OF SUCCESSFUL TRIAL OF 200kW CLASS 8 FCEV TRUCK WITH IMC LOGISTICS

HYZON ANNOUNCES COMPLETION OF SUCCESSFUL TRIAL OF 200kW CLASS 8 FCEV TRUCK WITH IMC LOGISTICS HYZON ANNOUNCES COMPLETION OF SUCCESSFUL TRIAL OF 200kW CLASS 8 FCEV TRUCK WITH IMC LOGISTICS PR Newswire...

HYZON SECURES FIRST HYDROGEN POWERED FUEL CELL ELECTRIC REFUSE TRUCK ORDER IN NORTH AMERICA FROM WASTE INDUSTRY PIONEER GREENWASTE

HYZON SECURES FIRST HYDROGEN POWERED FUEL CELL ELECTRIC REFUSE TRUCK ORDER IN NORTH AMERICA FROM WASTE INDUSTRY PIONEER GREENWASTE HYZON SECURES FIRST HYDROGEN POWERED FUEL CELL ELECTRIC REFUSE TRUCK...

HYZON SECURES ISO 9001 CERTIFICATION FOR FUEL CELL MANUFACTURING, DESIGN, AND RESEARCH AND DEVELOPMENT STANDARDS

HYZON SECURES ISO 9001 CERTIFICATION FOR FUEL CELL MANUFACTURING, DESIGN, AND RESEARCH AND DEVELOPMENT STANDARDS HYZON SECURES ISO 9001 CERTIFICATION FOR FUEL CELL MANUFACTURING, DESIGN, AND RESEARCH...

HYZON ANNOUNCES START OF PRODUCTION OF 200kW FUEL CELL SYSTEM, MARKING A MAJOR MILESTONE IN ZERO-EMISSION TECHNOLOGY ON NATIONAL HYDROGEN FUEL CELL DAY

HYZON ANNOUNCES START OF PRODUCTION OF 200kW FUEL CELL SYSTEM, MARKING A MAJOR MILESTONE IN ZERO-EMISSION TECHNOLOGY ON NATIONAL HYDROGEN FUEL CELL DAY HYZON ANNOUNCES START OF PRODUCTION OF 200kW...

Hyzon Regains Compliance with Nasdaq Listing Standards

Hyzon Regains Compliance with Nasdaq Listing Standards Hyzon Regains Compliance with Nasdaq Listing Standards PR Newswire BOLINGBROOK, Ill., Sept. 27, 2024 Nasdaq Has Informed the Company That a Bid...

Hyzon Motors, Inc. operates as a hydrogen mobility company. It engages in designing, developing, and manufacturing both standalone and integrated hydrogen fuel cells and systems as well as purpose-designed hydrogen-powered commercial vehicles. The company was founded in 2020 and is headquartered in Bolingbrook, IL.

Hyzon Motors Inc - Ordinary Shares - Class A

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '24	-$6.19	--	--	N/A
Q3 '24	-$6.38	-$7.74	-21.32%	MISSED
Q2 '24	-$0.16	-$10.50	-6674.19%	MISSED
Q1 '24	-$0.17	-$0.14	15.15%	BEAT
Q4 '23	-$0.20	-$0.20	--	EXPECTED

HYZN
Hyzon Motors Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '24

Historical Earnings

Latest HYZN News

HYZNHyzon Motors Inc - Ordinary Shares - Class A